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Div. phenotype diseases analysis, IRDA, Kumamoto University, Kumamoto, JapanRetinal neovascularization is accompanied by eye diseases such as
macular degeneration and diabetic retinopathy. Over-sustained or inap-
propriate endothelial cells (ECs) activation, and dysregulation of the
vascular network may cause severe retinal detachment and glaucoma,
ﬁnally leading to blindness. Blindness caused by such age-related dis-
eases is on the rise (Bourne et al., 2013), and should be an obstacle to
overcome in the days ahead for eye health. In spite of the well-
established role of VEGFA in pathological neovascularization, in this
issue of EBioMedicine, Singh et al. revealed that another isoform of
VEGF, VEGFC, is associated with retinal neovascularization (Singh
et al., 2015).
Angiogenesis is a vascular formation process in which ECs sprout
from the pre-existing blood vessels observed during development
and wound healing, and conceptually separated from de novo vessel
formation followed by EC differentiation from their precursors
(vasculogenesis). However, angiogenesis may occur in pathological
states (such as cancer), and promotes diseases—of which the best-
known stimulatory axis is VEGFA and its receptor VEGFR2. In contrast,
VEGFC-VEGFR3 axis is widely recognized as a promoter of lymph-
angiogenesis in adult in spite of its angiogenic role in early development
(Adams and Alitalo, 2007; Dumont et al., 1998).
With a more detailed cellular mechanism of angiogenesis, the “Tip-
stalk” hypothesis has been proposed. In this concept, some ECs are se-
lected as tip cells, characterized by high motility and low proliferation,
to sprout in response to the chemo-attractant such as VEGFA. In con-
trast, stalk cells characterized by high proliferation and low motility,
proliferate and elongate to form new blood vessels (Siekmann et al.,
2013). Tip and stalk cells signal via the DLL4-NOTCH axis: DLL4 expres-
sion is up-regulated in the tip cells in response to VEGF and subsequent-
ly DLL4 activates NOTCH signaling in the surrounding stalk ECs to
suppress the tip phenotype (Blanco and Gerhardt, 2013).
In this issue of EBioMedicine, Singh and colleagues show that VEGFC,
popular as a regulator of lymphangiogenesis, promoted proliferation,mi-
gration and angiogenesis in hypoxic retinal ECs. Further, the authors il-
lustrated the intra-cellular signaling pathway regulating the VEGFC-
induced angiogenesis: 1) VEGFC stimulation causes phosphorylation of
p38MAPK, 2) phosphorylated p38MAPK subsequently phosphorylates
transcription factor CREB, and 3) CREB upregulates DLL4 and NOTCH1,
which activates tip cells formation and consequently angiogenesis.
The authors ﬁrstly found that hypoxia, a major inducer of retinal
neovascularization, induced the expression of VEGFC as well as VEGFADOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.09.042.
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VEGFC indeed stimulated proliferation, migration and angiogenesis
in vitro. They also found that VEGFC stimulation caused phosphoryla-
tion of CREB, previously reported to be associated with intra-tumor an-
giogenesis following the EGR3 expression (Suehiro et al., 2010), and
demonstrated the necessity of CREB downstream of VEGFC using a
dominant-negative form of CREB. The importance of VEGFC and CREB
was further observed in oxygen-induced ischemic retinopathy (OIR)
mouse model by using gene targeting technique with siRNAs.
Given that VEGFC was reported to activate NOTCH signaling via
VEGFR3 during angiogenesis, Singh et al. next investigated whether
CREB activation upregulated the NOTCH signaling pathway. They ob-
served VEGFC-induced upregulation of DLL4, a NOTCH ligand, and acti-
vated form of NOTCH1 without upregulation of the other NOTCH-
associated molecules. The activation of DLL4-NOTCH1 was again
CREB-dependent; they identiﬁed a CREB-binding site at−193 bp up-
stream of the DLL4 promoter. In addition to the OIR mouse model,
they also used drug-inducible EC-speciﬁc CREB targeted mouse to
show the requirement of NOTCH signaling.
They lastly explored the kinase responsible for phosphorylating
CREB. Between two kinases phosphorylated by VEGFC stimulation,
p38MAPK was elegantly demonstrated to be the responsible kinase
for VEGFC-induced CREB phosphorylation, since introduction of
dominant-negative form of p38MAPK, not that of JNK1, canceled CREB
phosphorylation and the subsequent upregulation of DLL4/NOTCH1.
Phosphorylation of p38MAPK was indeed detected in hypoxic retina
in OIC model. Taken together, this in vitro and in vivo evidence points
to a model that VEGFC-induced p38MAPK-CREB-DLL4/NOTCH1 axis is
strongly associated with retinal neovascularization.
The authors' work promotes some further questions. Firstly, how
muchVEGFC contributes to retinal neovascularization compared to con-
ventionally well-reported VEGFA?While many papers have mentioned
the impact of DLL4-NOTCH signaling as beingdownstreamof VEGFA, in-
terestingly, the authors found that VEGFA cannot induce expression of
DLL4 and NOTCH1, despite the fact that VEGFA caused phosphorylation
of CREB. Related to this question, it is unclearwhich receptor is the part-
ner of VEGFC in the system described in this paper, given that VEGFC in-
duces dimerization of VEGFR2 and VEGFR3 as well as the canonical
VEGFR3 homodimer in the context of angiogenesis (Nilsson et al.,
2010). In addition to the intercellular signaling via VEGFC, it will be of
great interest to analyze whether VEGFR2- or VEGFR3-mediated phos-
phorylation cascades are dominant in retinal endothelial cells, for the
future progression of this work.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1589N. Nagai, T. Minami / EBioMedicine 2 (2015) 1588–1589VEGFC is now increasingly implied as an angiogenic factor not only
in developmental, but in pathological angiogenesis (Tammela et al.,
2008). Now, Singh and colleagues contribute new evidence of VEGFC-
induced pathological angiogenesis and have further clariﬁed a signaling
pathway critical for VEGFC-induced retinal angiogenesis, i.e. the
p38MAPK-CREB-DLL4/NOTCH1 axis. This may greatly contribute to
the development of novel strategies against retinal angiogenesis.
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